Rachel Culp-Hill, Ph.D.

Rachel Culp-Hill, Ph.D., holds the title of Mass Spectrometry Scientist and is recognized for her significant contributions to the field of metabolomics. With over ten years of experience in mass spectrometry, her research has primarily concentrated on studying metabolic alterations associated with various disease states such as acute myeloid leukemia, Down Syndrome, sickle cell disease, breast cancer, and hemorrhagic shock. Her groundbreaking work, particularly on the complex metabolome of acute myeloid leukemia stem cells and other cancers, has been published in prestigious scientific journals including Nature Medicine, Nature Cancer, Cell, Cancer Cell, Cell Stem Cell, and Blood. Dr. Culp-Hill is also actively involved in validating a diagnostic test for ovarian cancer and enhancing the capabilities of the GlycoLocateTM platform to detect additional cancer targets. She earned her Ph.D. in Biochemistry from the University of Colorado Anschutz Medical Campus, holds an M.Sc. in Microbiology from the University of Florida, and a B.S. in Biochemistry and Molecular Biology from Michigan State University.